FindTrial
Sign In

Blood inflammatory markers and diabetic nephropathy: a cross-sectional study

Blood inflammatory markers and diabetic nephropathy: a cross-sectional study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200063390
Enrollment
Unknown
Registered
2022-09-05
Start date
2022-09-01
Completion date
Unknown
Last updated
2023-04-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

diabetes

Interventions

group DKD:No intervention
non-DKD group:No intervention

Sponsors

Affiliated Hospital of Qingdao University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: Meet the diagnostic criteria in the American Diabetes Association (ADA) 2021 Diabetes Guidelines; No gender limitation; Age:18-80 years old.

Exclusion criteria

Exclusion criteria: Age 80 years with acute complications of T2DM, severe heart failure, severe liver disease, tumor, hematologic diseases such as lymphoma, leukemia, and unexplained hematopoietic dysfunction were excluded

Design outcomes

Primary

MeasureTime frame
Routine blood;Islet function;—

Countries

China

Contacts

Public ContactYangang Wang

Affiliated Hospital of Qingdao University

wangyg1966@126.com+86 18661807293

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026